Score Overview
Explore the 2021 public Archive ranking →
Where West Pharmaceutical Services Inc has ranked, year by year
Showing 10 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- WST
1996: 48.2% · 2021: 3.6% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 375.65 | — |
1 Year2025-09-26 | $ 260.71 | 44.09% |
5 Years2021-09-28 | $ 421.85 | -10.95% |
10 Years2016-09-28 | $ 72.08 | 421.12% |
20 Years2006-09-28 | $ 16.91 | 22x |
30 Years1996-09-27 | $ 4.35 | 86x |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | 30 Years1996-09-27 |
|---|---|---|---|---|---|---|
| Price | $ 375.65 | $ 260.71 | $ 421.85 | $ 72.08 | $ 16.91 | $ 4.35 |
| Return | — | 44.09% | -10.95% | 421.12% | 22x | 86x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 3.32B | $ 564M | $ 435M |
| 2025 | $ 3.07B | $ 493M | $ 791M |
| 2024 | $ 2.89B | $ 492M | $ 484M |
| 2023 | $ 2.95B | $ 593M | $ 853M |
| 2022 | $ 2.88B | $ 585M | $ 894M |
| 2021 | $ 2.83B | $ 661M | $ 762M |
| 2020 | $ 2.14B | $ 346M | $ 615M |
| 2019 | $ 1.84B | $ 241M | $ 439M |
| 2018 | $ 1.71B | $ 206M | $ 337M |
| 2017 | $ 1.59B | $ 150M | $ 235M |
| 2016 | $ 1.50B | $ 143M | $ 203M |
| 2015 | $ 1.39B | $ 95M | $ 274M |
| 2014 | $ 1.42B | $ 127M | $ 255M |
| 2013 | $ 1.36B | $ 112M | $ 237M |
| 2012 | $ 1.26B | $ 80M | $ 174M |
| 2011 | $ 1.19B | $ 75M | $ 91M |
| 2010 | $ 1.10B | $ 65M | $ 110M |
| 2009 | $ 1.05B | $ 72M | $ 83M |
| 2008 | $ 1.05B | $ 86M | $ 91M |
| 2007 | $ 1.02B | $ 70M | $ 129M |
| 2006 | $ 913M | $ 67M | $ 47M |
| 2005 | $ 699M | $ 45M | $ 48M |
| 2004 | $ 541M | $ 19M | $ 68M |
| 2003 | $ 490M | $ 31M | $ 37M |
| 2002 | $ 419M | $ 18M | $ 33M |
| 2001 | $ 396M | -$ 5M | $ 42M |
| 2000 | $ 430M | $ 1M | $ 42M |
| 1999 | $ 469M | $ 38M | $ 45M |
| 1998 | $ 449M | $ 6M | $ 31M |
| 1997 | $ 452M | $ 44M | $ 52M |
| 1996 | $ 458M | $ 16M | $ 27M |
| 1995 | $ 412M | $ 28M | $ 17M |
| 1994 | $ 365M | $ 27M | $ 27M |
| 1993 | $ 348M | $ 23M | $ 5M |
| 1992 | $ 338M | $ 19M | $ 3M |
| 1991 | $ 329M | -$ 8M | $ 2M |
| 1990 | $ 323M | $ 4M | $ 2M |
| 1989 | $ 308M | $ 20M | $ 1M |
| 1988 | $ 288M | $ 17M | $ 5M |
| 1987 | $ 253M | $ 13M | $ 12M |
| 1986 | $ 235M | $ 17M | $ 7M |
| 1985 | $ 190M | $ 15M | $ 8M |
West Pharmaceutical Services Inc fundamental performance
Between 2005 and 2025, revenue grew from $ 699M to $ 3.07B and net income grew from $ 45M to $ 493M. Revenue increased in 18 of those 20 years; net income in 15.
Across West Pharmaceutical Services Inc's full reported history, from 1985 to 2025, revenue grew from $ 190M to $ 3.07B and net income grew from $ 15M to $ 493M. Revenue increased in 85% of the years measured; net income in 68%.
West Pharmaceutical Services Inc currently holds a 20-year HDB Score of 8.1 out of 10. How the HDB Score is calculated.
Membership
Continue WST’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
Explore other companies
Universal Health Services IncUHS· revenue grew in 95% of years
Mettler-Toledo International IncMTD· revenue grew in 85% of years
UFP Technologies IncUFPT· revenue grew in 80% of years
UnitedHealth Group IncorporatedUNH· revenue grew in 100% of years
Edwards Lifesciences CorpEW· revenue grew in 95% of years
